'Designer Xanax' Banned Nationwide After 22 States Urged DEA to Change Its Rules
The DEA classified bromazolam as Schedule I citing no medical use and high abuse risk after Kentucky reported 48 overdose deaths in 2024, prompting a 21-state coalition push.
- The Drug Enforcement Administration formally added bromazolam to Schedule I, citing its high potential for abuse and lack of accepted medical use.
- Following alarms from the Northern Kentucky Drug Strike Force, Coleman led a 21-state coalition urging the DEA to schedule bromazolam, a synthetic drug used for counterfeit Xanax.
- Counterfeit medication sold as "Designer Xanax" contributed to nearly 50 overdose deaths in 2024, proving highly lethal when combined with opioids or depressants.
- DEA Assistant Administrator Cheri said the emergency move 'closes dangerous gaps' and provides law enforcement with new tools to disrupt access to bromazolam.
- Officials continue working to stay ahead; Kentuckians can report information about dangerous substances anonymously through the Northern Kentucky Drug Strike Force website, DEA says "closes dangerous gaps".
18 Articles
18 Articles
Coleman leads 21-state effort to ban potent street drug
FRANKFORT, Ky. (KT) – Kentucky Attorney General Russell Coleman announced on Wednesday that the Trump Administration has acted on his request to create a nationwide ban on a drug that contributed to the deaths of nearly 50 Kentuckians. This week, the U.S. Drug Enforcement Administration (DEA) formally added bromazolam to the federal schedule of controlled substances. A Schedule I drug designation empowers law enforcement across the country to cr…
DEA answers AG Coleman’s call to ban "Designer Xanax" nationwide
HENDERSON, Ky. (WEHT) - Attorney General Russell Coleman announced the Trump Administration acted on his request to create a nationwide ban on a drug that contributed to the deaths of nearly 50 Kentuckians - what AG Coleman calls "Designer Xanax." AG Coleman says this week, the U.S. Drug Enforcement Administration (DEA) formally added bromazolam to [...]
'Designer Xanax' banned nationwide after 22 states urged DEA to change its rules
The U.S. Drug Enforcement Administration this week formally added bromazolam to the federal schedule of controlled substances, following a push from a 22-state coalition that called on the Trump Administration to act, Coleman announced.The Schedule I designation gives law enforcement across the country new authority to crack down on bromazolam and increases awareness of the drug's potentially deadly effects, Kentucky Attorney General Russell Col…
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium










